APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17421468021 May 2026196 pages

Choose your research edition.

Industry ResearchPharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service include SGS, Quanticate, Mercodia, Creative Biolabs, Allucent, IRBM, Pacific BioLabs, Altasciences and Celerion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Segment by Company

SGS

Quanticate

Mercodia

Creative Biolabs

Allucent

IRBM

Pacific BioLabs

Altasciences

Celerion

Labcorp

Oncodesign Services

Drug Development Solutions

CD BioSciences

Creative-Bioarray

Biotrial

Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Segment by Type

In Vivo PK and PD Service

PK and PD modelling

DMPK Analysis

Ligand-Binding

Others

Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Segment by Application

Pharmaceutical Company

Research Institute

Others

Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service industry.

Chapter 3: Detailed analysis of Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of In Vivo PK and PD Service Table 3. Key Players of PK and PD modelling Table 4. Key Players of DMPK Analysis Table 3. Key Players of Ligand-Binding Table 4. Key Players of Others Table 5. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Pharmaceutical Company Table 7. Key Players of Research Institute Table 8. Key Players of Others Table 9. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Region (2021-2026) Table 12. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Region (2027-2032) Table 14. Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Trends Table 15. Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Drivers Table 16. Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Opportunities and Challenges Table 17. Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Restraints Table 18. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue Market Share by Company (2021-2026) Table 20. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Key Company Head Office and Area Served Table 22. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Company, Product Type & Application Table 23. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue Market Share by Type (2021-2026) Table 30. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue Market Share by Type (2027-2032) Table 31. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue Market Share by Application (2021-2026) Table 35. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue Market Share by Application (2027-2032) Table 36. SGS Company Information Table 37. SGS Business Overview Table 38. SGS Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. SGS Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 40. SGS Recent Development Table 41. Quanticate Company Information Table 42. Quanticate Business Overview Table 43. Quanticate Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Quanticate Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 45. Quanticate Recent Development Table 46. Mercodia Company Information Table 47. Mercodia Business Overview Table 48. Mercodia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Mercodia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 50. Mercodia Recent Development Table 51. Creative Biolabs Company Information Table 52. Creative Biolabs Business Overview Table 53. Creative Biolabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Creative Biolabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 55. Creative Biolabs Recent Development Table 56. Allucent Company Information Table 57. Allucent Business Overview Table 58. Allucent Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Allucent Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 60. Allucent Recent Development Table 61. IRBM Company Information Table 62. IRBM Business Overview Table 63. IRBM Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. IRBM Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 65. IRBM Recent Development Table 66. Pacific BioLabs Company Information Table 67. Pacific BioLabs Business Overview Table 68. Pacific BioLabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Pacific BioLabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 70. Pacific BioLabs Recent Development Table 71. Altasciences Company Information Table 72. Altasciences Business Overview Table 73. Altasciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Altasciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 75. Altasciences Recent Development Table 76. Celerion Company Information Table 77. Celerion Business Overview Table 78. Celerion Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Celerion Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 80. Celerion Recent Development Table 81. Labcorp Company Information Table 82. Labcorp Business Overview Table 83. Labcorp Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Labcorp Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 85. Labcorp Recent Development Table 86. Oncodesign Services Company Information Table 87. Oncodesign Services Business Overview Table 88. Oncodesign Services Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Oncodesign Services Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 90. Oncodesign Services Recent Development Table 91. Drug Development Solutions Company Information Table 92. Drug Development Solutions Business Overview Table 93. Drug Development Solutions Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Drug Development Solutions Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 95. Drug Development Solutions Recent Development Table 96. CD BioSciences Company Information Table 97. CD BioSciences Business Overview Table 98. CD BioSciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. CD BioSciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 100. CD BioSciences Recent Development Table 101. Creative-Bioarray Company Information Table 102. Creative-Bioarray Business Overview Table 103. Creative-Bioarray Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Creative-Bioarray Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 105. Creative-Bioarray Recent Development Table 106. Biotrial Company Information Table 107. Biotrial Business Overview Table 108. Biotrial Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Biotrial Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 110. Biotrial Recent Development Table 111. North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2021-2026) & (US$ Million) Table 112. North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2027-2032) & (US$ Million) Table 113. North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2021-2026) & (US$ Million) Table 114. North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2027-2032) & (US$ Million) Table 115. North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2021-2026) Table 117. North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2027-2032) Table 118. Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2021-2026) & (US$ Million) Table 119. Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2027-2032) & (US$ Million) Table 120. Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2021-2026) & (US$ Million) Table 121. Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2027-2032) & (US$ Million) Table 122. Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2021-2026) Table 124. Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2027-2032) Table 125. China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2021-2026) & (US$ Million) Table 126. China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2027-2032) & (US$ Million) Table 127. China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2021-2026) & (US$ Million) Table 128. China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2027-2032) & (US$ Million) Table 129. Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2021-2026) & (US$ Million) Table 130. Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2027-2032) & (US$ Million) Table 131. Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2021-2026) & (US$ Million) Table 132. Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2027-2032) & (US$ Million) Table 133. Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2021-2026) Table 135. Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2027-2032) Table 136. South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2021-2026) & (US$ Million) Table 137. South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2027-2032) & (US$ Million) Table 138. South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2021-2026) & (US$ Million) Table 139. South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2027-2032) & (US$ Million) Table 140. South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2021-2026) Table 142. South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Image Figure 2. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Type: 2025 VS 2032 Figure 4. In Vivo PK and PD Service Image Figure 5. PK and PD modelling Image Figure 6. DMPK Analysis Image Figure 7. Ligand-Binding Image Figure 8. Others Image Figure 9. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Application: 2025 VS 2032 Figure 11. Pharmaceutical Company Image Figure 12. Research Institute Image Figure 13. Others Image Figure 14. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 16. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue Market Share by Type (2021-2032) Figure 23. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue Market Share by Application (2021-2032) Figure 25. North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 26. North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Type (2021-2032) Figure 27. North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Application (2021-2032) Figure 28. North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Country (2021-2032) Figure 29. United States Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 30. Canada Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 32. Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 33. Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Type (2021-2032) Figure 34. Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Application (2021-2032) Figure 35. Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Country (2021-2032) Figure 36. Germany Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 37. France Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 39. Italy Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 40. Russia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 42. China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 43. China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Type (2021-2032) Figure 44. China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Application (2021-2032) Figure 45. Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 46. Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Type (2021-2032) Figure 47. Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Application (2021-2032) Figure 48. Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Country (2021-2032) Figure 49. Japan Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 53. India Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 54. Australia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Country (2021-2032) Figure 59. Brazil Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 64. UAE Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 66. Chile Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • In Vivo PK and PD Service
  • PK and PD modelling
  • DMPK Analysis
  • Ligand-Binding
  • Others
Applications
  • Pharmaceutical Company
  • Research Institute
  • Others
Companies covered
  • SGS
  • Quanticate
  • Mercodia
  • Creative Biolabs
  • Allucent
  • IRBM
  • Pacific BioLabs
  • Altasciences
  • Celerion
  • Labcorp
  • Oncodesign Services
  • Drug Development Solutions
  • CD BioSciences
  • Creative-Bioarray
  • Biotrial

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 In Vivo PK and PD Service
  5. 1.2.3 PK and PD modelling
  6. 1.2.4 DMPK Analysis
  7. 1.2.5 Ligand-Binding
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Pharmaceutical Company
  12. 1.3.3 Research Institute
  13. 1.3.4 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Growth Trends by Region
  16. 1.5.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Region (2021-2026)
  18. 1.5.3 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Dynamics
  1. 2.1 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Trends
  2. 2.2 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Drivers
  3. 2.3 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Opportunities and Challenges
  4. 2.4 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue by Company (2021-2026)
  2. 3.2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Key Company Head office and Area Served
  4. 3.4 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Company, Product Type & Application
  5. 3.5 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Tier 1, Tier 2, and Tier 3
4 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market by Type
  1. 4.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2021-2032)
  3. 4.3 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size Share by Type (2021-2032)
5 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market by Application
  1. 5.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2021-2032)
  3. 5.3 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 SGS
  2. 6.1.1 SGS Company Information
  3. 6.1.2 SGS Business Overview
  4. 6.1.3 SGS Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 SGS Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  6. 6.1.5 SGS Recent Developments
  7. 6.2 Quanticate
  8. 6.2.1 Quanticate Company Information
  9. 6.2.2 Quanticate Business Overview
  10. 6.2.3 Quanticate Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Quanticate Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  12. 6.2.5 Quanticate Recent Developments
  13. 6.3 Mercodia
  14. 6.3.1 Mercodia Company Information
  15. 6.3.2 Mercodia Business Overview
  16. 6.3.3 Mercodia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Mercodia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  18. 6.3.5 Mercodia Recent Developments
  19. 6.4 Creative Biolabs
  20. 6.4.1 Creative Biolabs Company Information
  21. 6.4.2 Creative Biolabs Business Overview
  22. 6.4.3 Creative Biolabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Creative Biolabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  24. 6.4.5 Creative Biolabs Recent Developments
  25. 6.5 Allucent
  26. 6.5.1 Allucent Company Information
  27. 6.5.2 Allucent Business Overview
  28. 6.5.3 Allucent Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Allucent Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  30. 6.5.5 Allucent Recent Developments
  31. 6.6 IRBM
  32. 6.6.1 IRBM Company Information
  33. 6.6.2 IRBM Business Overview
  34. 6.6.3 IRBM Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 IRBM Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  36. 6.6.5 IRBM Recent Developments
  37. 6.7 Pacific BioLabs
  38. 6.7.1 Pacific BioLabs Company Information
  39. 6.7.2 Pacific BioLabs Business Overview
  40. 6.7.3 Pacific BioLabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Pacific BioLabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  42. 6.7.5 Pacific BioLabs Recent Developments
  43. 6.8 Altasciences
  44. 6.8.1 Altasciences Company Information
  45. 6.8.2 Altasciences Business Overview
  46. 6.8.3 Altasciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Altasciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  48. 6.8.5 Altasciences Recent Developments
  49. 6.9 Celerion
  50. 6.9.1 Celerion Company Information
  51. 6.9.2 Celerion Business Overview
  52. 6.9.3 Celerion Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Celerion Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  54. 6.9.5 Celerion Recent Developments
  55. 6.10 Labcorp
  56. 6.10.1 Labcorp Company Information
  57. 6.10.2 Labcorp Business Overview
  58. 6.10.3 Labcorp Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Labcorp Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  60. 6.10.5 Labcorp Recent Developments
  61. 6.11 Oncodesign Services
  62. 6.11.1 Oncodesign Services Company Information
  63. 6.11.2 Oncodesign Services Business Overview
  64. 6.11.3 Oncodesign Services Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Oncodesign Services Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  66. 6.11.5 Oncodesign Services Recent Developments
  67. 6.12 Drug Development Solutions
  68. 6.12.1 Drug Development Solutions Company Information
  69. 6.12.2 Drug Development Solutions Business Overview
  70. 6.12.3 Drug Development Solutions Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Drug Development Solutions Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  72. 6.12.5 Drug Development Solutions Recent Developments
  73. 6.13 CD BioSciences
  74. 6.13.1 CD BioSciences Company Information
  75. 6.13.2 CD BioSciences Business Overview
  76. 6.13.3 CD BioSciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 CD BioSciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  78. 6.13.5 CD BioSciences Recent Developments
  79. 6.14 Creative-Bioarray
  80. 6.14.1 Creative-Bioarray Company Information
  81. 6.14.2 Creative-Bioarray Business Overview
  82. 6.14.3 Creative-Bioarray Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Creative-Bioarray Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  84. 6.14.5 Creative-Bioarray Recent Developments
  85. 6.15 Biotrial
  86. 6.15.1 Biotrial Company Information
  87. 6.15.2 Biotrial Business Overview
  88. 6.15.3 Biotrial Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Biotrial Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  90. 6.15.5 Biotrial Recent Developments
7 North America
  1. 7.1 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032)
  2. 7.2 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type
  3. 7.2.1 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Type (2021-2032)
  6. 7.3 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application
  7. 7.3.1 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Application (2021-2032)
  10. 7.4 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country
  11. 7.4.1 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032)
  2. 8.2 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type
  3. 8.2.1 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Type (2021-2032)
  6. 8.3 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application
  7. 8.3.1 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Application (2021-2032)
  10. 8.4 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country
  11. 8.4.1 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032)
  2. 9.2 China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type
  3. 9.2.1 China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2021-2026)
  4. 9.2.2 China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2027-2032)
  5. 9.2.3 China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Type (2021-2032)
  6. 9.3 China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application
  7. 9.3.1 China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2021-2026)
  8. 9.3.2 China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2027-2032)
  9. 9.3.3 China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032)
  2. 10.2 Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type
  3. 10.2.1 Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Type (2021-2032)
  6. 10.3 Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application
  7. 10.3.1 Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Application (2021-2032)
  10. 10.4 Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country
  11. 10.4.1 Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst